Novartis receives three FDA Breakthrough Therapy Designations for Ilaris
Novartis announced that the US FDA has granted three Breakthrough Therapy Designations for Ilaris® (canakinumab) to treat three rare types of Periodic Fever Syndromes,...
Quality and Clean Room Microenvironment Created by Innovation: EP & Clean Tech China launches the Discovery Tour onAir Treatment
Guaranteed drug quality and promoted drug reliability are foundation for the success of all pharmaceuticals. Cleanliness is considered to be an area of the...
Boehringer Ingelheim initiates pivotal programme for novel third-generation EGFR targeting lung cancer compound
• First patients enrolled in pivotal Phase II global trial evaluating BI 1482694 (HM61713) in patients with T790M mutation-positive NSCLC• Boehringer Ingelheim aims to...
Biomedica Launches First CE Marked FGF23 ELISA Assay In Europe and Asia
The biomarker specialists at Biomedica Immunoassays, announced the launch of the first CE marked FGF23 (C-terminal) ELISA assay which specifically detects both intact and...
Largest Ever in Scale! CPhI drives 500 exhibitors from 30 countries and regions
Global standardization has been one of the key trendsin the Japanese pharmaceutical industry over the past decade.This has been shapedby the revision of the...
PTC’s Translarna receives conditional approval for nonsense mutation DMD in EU
The European Commission has given conditional marketing authorisation for biopharmaceutical company PTC Therapeutics' Translarna (ataluren) in the EU. Translarna is a treatment for the...
Pharmaceuticals Learning the Language of the New Healthcare Landscape
With monumental health reform coming into effect, the pharmaceutical industry is learning to speak a second language. Clinical efficacy is no longer the sole...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...